# A Pharmacokinetic and Pharmacodynamic Study of DZ-002 in Patients With Advanced Solid Malignancies or Lymphoma

> **NCT04970992** · PHASE1 · COMPLETED · sponsor: **Da Zen Theranostics Inc** · enrollment: 14 (actual)

## Conditions studied

- Solid Tumor
- Lymphoma

## Interventions

- **DRUG:** DZ-002

## Key facts

- **NCT ID:** NCT04970992
- **Lead sponsor:** Da Zen Theranostics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-12
- **Primary completion:** 2024-11-07
- **Final completion:** 2025-04-01
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04970992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04970992, "A Pharmacokinetic and Pharmacodynamic Study of DZ-002 in Patients With Advanced Solid Malignancies or Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04970992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*